Lilly(Eli) & Overview
Lilly(Eli) & Target Price
Analysts' 12-month price predictions for LLY.
Share Price
$770
Average Target Price
$839.33
9% upside
9% upside6 analysts in the last 4 months
High: $1001 | Low: $535
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2024-05-16 | Wells FargoMohit Bansal | $875 | 13.6% upside |  |
| 2024-05-14 | Argus ResearchDavid Toung | $840 | 9.1% upside | |
| 2024-05-01 | BMO CapitalEvan Seigerman | $1,001 | 30% upside | |
| 2024-04-30 | Cantor FitzgeraldLouise Chen | $885 | 14.9% upside | |
| 2024-04-18 | BMO CapitalEvan David Seigerman | $900 | 16.9% upside | |
| 2024-02-06 | Deutsche BankJames Shin | $535 |  30.5% downside | |
| 2023-12-28 | CitigroupAndrew Baum | $675 | 12.3% downside | |
| 2023-10-11 | Morgan StanleyDavid Phung | $673 | 12.6% downside | |
| 2023-08-09 | Morgan StanleyTerence Flynn | $617 | 19.9% downside | |
| 2023-08-09 | Cantor FitzgeraldLouise Chen | $630 | 18.2% downside | |
| 2023-02-03 | Wells Fargo | $360 | 53.2% downside | |
| 2023-02-03 | Morgan Stanley | $455 | 40.9% downside | |
| 2023-01-03 | Barclays | $400 | 48.1% downside | |
| 2022-12-17 | Cowen & Co.Cowen Cowen | $430 | 44.2% downside | |
| 2022-12-16 | Leerink Partners | $410 | 46.8% downside | |
| 2022-12-15 | UBS | $420 | 45.5% downside | |
| 2022-12-14 | Morgan Stanley | $440 | 42.9% downside | |
| 2022-12-08 | Wells Fargo | $375 | 51.3% downside | |
| 2022-12-07 | Guggenheim | $401 | 47.9% downside | |
| 2022-12-06 | Morgan Stanley | $446 | 42.1% downside | |
| 2022-12-06 | Credit Suisse | $400 | 48.1% downside | |
| 2022-11-18 | Credit Suisse | $395 | 48.7% downside | |
| 2022-11-17 | Morgan Stanley | $436 | 43.4% downside | |
| 2022-10-02 | UBSColin Bristow Bristow | $336 | 56.4% downside | |
| 2022-09-22 | UBSNavin Jacob | $363 | 52.9% downside | |
| 2022-09-07 | Morgan Stanley | $412 | 46.5% downside | |
| 2022-09-06 | BMO Capital | $396 | 48.6% downside | |
| 2022-07-08 | Morgan Stanley | $395 | 48.7% downside | |
| 2022-07-07 | Barclays | $355 | 53.9% downside | |
| 2022-06-01 | J.P. Morgan | $355 | 53.9% downside | |
| 2022-05-23 | Leerink PartnersDavid Risinger | $341 | 55.7% downside | |
| 2022-05-09 | UBSNavin Jacob | $293 | 61.9% downside | |
| 2022-05-08 | BMO CapitalEvan David Seigerman | $358 | 53.5% downside | |
| 2022-05-03 | Mizuho SecuritiesVamil Divan | $356 | 53.8% downside | |
| 2022-04-30 | Wells FargoMohit Bansal | $305 | 60.4% downside | |
| 2022-04-29 | Morgan Stanley | $369 | 52.1% downside | |
| 2022-04-11 | Morgan StanleyTerence Flynn | $364 | 52.7% downside | |
| 2022-03-26 | Bank of America SecuritiesGeoff Meacham | $315 | 59.1% downside | |
| 2022-02-06 | Morgan StanleyMatthew Harrison | $265 | 65.6% downside | |
| 2022-01-30 | Cantor FitzgeraldLouise Chen | $335 | 56.5% downside | |
| 2022-01-04 | Wells FargoMohit Bansal | $280 | 63.6% downside | |
| 2022-01-03 | BernsteinAaron Gal | $300 | 61% downside | |
| 2021-12-20 | BarclaysCarter Gould | $325 | 57.8% downside | |
| 2021-12-17 | Goldman SachsChris Shibutani | $236 | 69.4% downside | |
| 2021-12-16 | J.P. MorganChris Schott | $325 | 57.8% downside | |
| 2021-12-07 | CitigroupAndrew Baum | $265 | 65.6% downside | |
| 2021-11-29 | UBSNavin Jacob | $267 | 65.3% downside | |
| 2021-09-21 | GuggenheimSeamus Fernandez | $266 | 65.5% downside | |
| 2021-08-30 | Cowen & Co.Steve Scala | $300 | 61% downside | |
| 2021-08-09 | Argus ResearchDavid Toung | $300 | 61% downside | |